63
Participants
Start Date
December 19, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
July 31, 2020
PTG-300
Subcutaneous (SC)
Bone Marrow Transplant Center, Tunis
Aziza Othmana Hospital, Tunis
Principal Military Hospital, Tunis
University Hospital Farhat Hached, Sousse
Chulalongkorn University, Bangkok
Siriraj Hospital Mahidol University, Bangkok
Hospital Pulau Pinang, George Town
Laiko General Hospital of Athens, Athens
Hospital of The University of Pennsylvania, Philadelphia
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Mersin University Medical Facult, Mersin
Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul
Ege Universitesi Tip Fakultesi, Izmir
Khon Kaen University, Khon Kaen
Maharaj Nakorn Chiang Mai Chiang Mai University, Chiang Mai
Naresuan University, Phitsanulok
Hospital Ampang, Ampang
Presidio Ospedaliero Antonio Perrino, Brindisi
Hospital Sultanah Aminah, Johor Bahru
AOU dell'Università degli Studi della Campania Luigi Vanvitelli, Napoli
Queen Elizabeth Hospital, Kota Kinabalu
Hospital Umum Sarawak, Kuching
UCSF Benioff Children's Hospital, Oakland
Boston Children's Hospital, Boston
University General Hospital of Patras, Pátrai
Athens General Hospital 'G Gennimatas', Athens
Hippokration Hospital, Thessaloniki
Chronic Care Center, Beirut
Barts Health NHS Trust, London
Acibadem Adana Hospital, Adana
Hacettepe University Medical Faculty, Ankara
Akdeniz Universitesi Hastanesi, Antalya
Barts Health NHS Trust, London
Protagonist Therapeutics, Inc.
INDUSTRY